Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

CStone Pharmaceuticals CSPHF

Set alert

Price alert · CSPHF

All alert types
0.91 USD +0.16 +20.65%

At close · Oct 30

0.9108 Day range 0.9109
0.595 52-week range 1.01
YTD
+2.00%
1 year
+2.00%
Open
0.9108
Prev close
0.755
Mkt cap
1.45B
Vol
2.00K
Avg vol
1.01K
EPS
-0.04
P/E
0.00
More statistics
Low
0.9108
High
0.9109
Earnings
Aug 20, 2026

3M chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Aug 20, 2026Earnings: —; estimate -0.02796; surprise —%
Signals (13)
NameDateAgo
SMA: BullishOct 28, 20265 days ago
MACD: Buy SignalOct 14, 20262 weeks ago
SMA: BullishSep 30, 20261 month ago
RSI: OversoldSep 28, 20261 month ago
SMA: BearishSep 21, 20261 month ago
SMA: BearishSep 21, 20261 month ago
MACD: Sell SignalSep 21, 20261 month ago
SMA: BullishSep 4, 20261 month ago
MACD: Buy SignalSep 4, 20261 month ago
RSI: OverboughtSep 4, 20261 month ago
RSI: OversoldSep 1, 20262 months ago
MACD: Sell SignalAug 11, 20262 months ago
SMA: BullishJul 31, 20263 months ago

Financial health

Altman Z-Score

7.92 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C-1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 2
  • P/E 1
  • P/B 2

Valuation

P/E -20.1×
FY 2016: -30.5×FY 2017: -22.4×FY 2018: -2.7×FY 2019: -3.2×FY 2020: -6.3×FY 2021: -4.8×FY 2022: -5.3×FY 2023: -7.9×FY 2024: -23.1×FY 2025: -20.1×
FY 2016 5y median -7.9× FY 2025
P/S 33.0×
FY 2016: 0.0×FY 2017: 676×FY 2018: 587×FY 2019: 0.0×FY 2020: 7.4×FY 2021: 37.6×FY 2022: 9.9×FY 2023: 6.2×FY 2024: 5.2×FY 2025: 33.0×
FY 2016 5y median 9.9× FY 2025
P/B 14.0×
FY 2016: 10.5×FY 2017: 16.3×FY 2018: 14.3×FY 2019: 2.7×FY 2020: 2.6×FY 2021: 7.6×FY 2022: 10.6×FY 2023: 6.3×FY 2024: 5.8×FY 2025: 14.0×
FY 2016 5y median 7.6× FY 2025
P/FCF -26.5×
FY 2016: -35.1×FY 2017: -27.6×FY 2018: -9.2×FY 2019: -6.1×FY 2020: -13.3×FY 2021: -5.6×FY 2022: -6.7×FY 2023: -4.4×FY 2024: -6.1×FY 2025: -26.5×
FY 2016 5y median -6.1× FY 2025
EV/EBITDA -21.9×
FY 2016: -28.4×FY 2017: -28.5×FY 2018: -6.5×FY 2019: -3.2×FY 2020: -3.9×FY 2021: -4.5×FY 2022: -5.3×FY 2023: -7.6×FY 2024: -79.0×FY 2025: -21.9×
FY 2016 5y median -7.6× FY 2025
EV/Sales 31.5×
FY 2016: 0.0×FY 2017: 668×FY 2018: 531×FY 2019: 0.0×FY 2020: 4.6×FY 2021: 35.3×FY 2022: 9.4×FY 2023: 4.8×FY 2024: 5.1×FY 2025: 31.5×
FY 2016 5y median 9.4× FY 2025
FCF Yield -3.8%
FY 2016: -2.8%FY 2017: -3.6%FY 2018: -10.9%FY 2019: -16.5%FY 2020: -7.5%FY 2021: -17.8%FY 2022: -15.0%FY 2023: -22.7%FY 2024: -16.3%FY 2025: -3.8%
FY 2016 5y median -16.3% FY 2025

Profitability

Gross Margin 17.1%
FY 2016: 0.0%FY 2017: 100.0%FY 2018: 100.0%FY 2019: 0.0%FY 2020: 76.8%FY 2021: 56.2%FY 2022: 57.8%FY 2023: 65.6%FY 2024: 59.0%FY 2025: 17.1%
FY 2016 5y median 57.8% FY 2025
Operating Margin -160.5%
FY 2016: 0.0%FY 2017: -2354.1%FY 2018: -8196.3%FY 2019: 0.0%FY 2020: -105.1%FY 2021: -750.6%FY 2022: -189.5%FY 2023: -125.0%FY 2024: -22.5%FY 2025: -160.5%
FY 2016 5y median -160.5% FY 2025
Net Margin -162.1%
FY 2016: 0.0%FY 2017: -2999.1%FY 2018: -13906.6%FY 2019: 0.0%FY 2020: -117.4%FY 2021: -787.8%FY 2022: -187.5%FY 2023: -79.2%FY 2024: -22.4%FY 2025: -162.1%
FY 2016 5y median -162.1% FY 2025
ROE -69.0%
FY 2016: -34.5%FY 2017: -72.5%FY 2018: -338.7%FY 2019: -93.0%FY 2020: -41.3%FY 2021: -159.1%FY 2022: -200.9%FY 2023: -80.4%FY 2024: -25.1%FY 2025: -69.0%
FY 2016 5y median -80.4% FY 2025
ROIC -40.5%
FY 2016: -34.2%FY 2017: -53.8%FY 2018: -196.7%FY 2019: -69.6%FY 2020: -35.8%FY 2021: -132.3%FY 2022: -123.8%FY 2023: -61.0%FY 2024: -11.4%FY 2025: -40.5%
FY 2016 5y median -61.0% FY 2025
ROA -31.3%
FY 2016: -29.8%FY 2017: -54.7%FY 2018: -106.9%FY 2019: -78.2%FY 2020: -32.4%FY 2021: -84.5%FY 2022: -55.1%FY 2023: -22.1%FY 2024: -6.5%FY 2025: -31.3%
FY 2016 5y median -31.3% FY 2025

Growth (YoY)

Revenue -35.5%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 21.8%FY 2019: -100.0%FY 2020: 0.0%FY 2021: -76.5%FY 2022: 97.5%FY 2023: -3.6%FY 2024: -12.2%FY 2025: -35.5%
FY 2016 FY 2025
Operating Income -359.6%
FY 2016: 0.0%FY 2017: 7.5%FY 2018: -324.2%FY 2019: -68.9%FY 2020: 37.1%FY 2021: -67.5%FY 2022: 50.1%FY 2023: 36.4%FY 2024: 84.2%FY 2025: -359.6%
FY 2016 FY 2025
EPS (diluted) -333.6%
FY 2016: 0.0%FY 2017: -24.0%FY 2018: -800.0%FY 2019: 14.3%FY 2020: 51.0%FY 2021: -41.0%FY 2022: 53.3%FY 2023: 62.3%FY 2024: 75.3%FY 2025: -333.6%
FY 2016 FY 2025
Free Cash Flow 4.5%
FY 2016: 0.0%FY 2017: -18.0%FY 2018: -216.2%FY 2019: -36.6%FY 2020: 46.9%FY 2021: -181.8%FY 2022: 56.3%FY 2023: 8.5%FY 2024: 47.5%FY 2025: 4.5%
FY 2016 FY 2025

Financial Health

Current Ratio 2.2×
FY 2016: 13.9×FY 2017: 4.8×FY 2018: 1.4×FY 2019: 6.3×FY 2020: 4.9×FY 2021: 2.1×FY 2022: 1.3×FY 2023: 1.6×FY 2024: 1.6×FY 2025: 2.2×
FY 2016 5y median 1.6× FY 2025
Quick Ratio 2.0×
FY 2016: 13.9×FY 2017: 4.8×FY 2018: 1.4×FY 2019: 6.3×FY 2020: 4.9×FY 2021: 2.0×FY 2022: 1.3×FY 2023: 1.4×FY 2024: 1.2×FY 2025: 2.0×
FY 2016 5y median 1.4× FY 2025
Debt / Equity 0.6×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.1×FY 2022: 0.6×FY 2023: 0.8×FY 2024: 1.0×FY 2025: 0.6×
FY 2016 5y median 0.6× FY 2025
Net Debt / EBITDA 1.1×
FY 2016: 0.2×FY 2017: 0.3×FY 2018: 0.7×FY 2019: 0.7×FY 2020: 2.4×FY 2021: 0.3×FY 2022: 0.3×FY 2023: 2.1×FY 2024: 1.2×FY 2025: 1.1×
FY 2016 5y median 1.1× FY 2025
Interest Coverage -32.6×
FY 2016: -1092×FY 2017: -4041×FY 2018: 0.0×FY 2019: 0.0×FY 2020: -827×FY 2021: -816×FY 2022: -108×FY 2023: -49.1×FY 2024: -6.0×FY 2025: -32.6×
FY 2016 5y median -49.1× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31